Missouri

Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster

Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.

August 27, 2024

2 min read

Tristan Manalac

PRESS RELEASES

Business

Stowers Institute for Medical Research appoints new Assistant Investigator

April 30, 2024

3 min read

Drug Development

Vivacelle Bio and University of Missouri-Kansas City School of Medicine Announce Groundbreaking Results from Phase 2a Clinical Trial of VBI-S for Refractory Hypotension in Severe Septic Shock Patients

February 29, 2024

5 min read

BioMidwest

Defender Pharmaceuticals Receives Complete Response Letter from the U.S. Food and Drug Administration for its Intranasal Scopolamine (DPI-386) New Drug Application for the Prevention of Nausea and Vomiting Induced by Motion in Adults

January 30, 2024

4 min read

Business

Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Options for Patients with Inflammatory Bowel Disease

December 5, 2023

5 min read

Business

Kansas City University Recognized for “Groundbreaking” Pancreatic Cancer Research

August 24, 2023

3 min read

BioMidwest

Stowers scientists find evidence of unintended impacts from anti-cancer drugs

August 23, 2023

4 min read

BioMidwest

Defender Pharmaceuticals Phase 3 Motion Sickness Trial Results Selected for Presentation at 2023 Military Health System Research Symposium (MHSRS)

August 10, 2023

7 min read

BioMidwest

Defender Pharmaceuticals Announces Exclusive License Agreement with the U.S. Army for the Development of Products to Treat Tropical Diseases

July 31, 2023

5 min read

BioMidwest

Defender Pharmaceuticals Announces Submission of New Drug Application to FDA with Intranasal Scopolamine for Prevention of Nausea and Vomiting Induced by Motion in Adults

July 26, 2023

7 min read